ebook Munafa Stock Market Course + Intraday & FNO calls  

       

524816 announcements Natco Pharm announcements and dividends declared BSE

Natco Pharm Complete list of announcements declared & dividend announcements by Natco Pharm 524816

Natco Pharm 524816 listed on BSE and deals in

Announcements and dividends declared by Natco Pharm 524816

Natco Pharma Q1 results: Profit falls 57% to ?206 cr, revenue at ?735 cr
Natco Pharma Ltd on Friday reported a 57 per cent decline in consolidated net profit at Rs 206.5 crore in the first quarter ended June 2026, hit by lower sales of its generic cancer treatment drug lenalidomide. The company had posted a consolidated net pro
Announcement as on 14 August 2026

Natco Pharma Q1 profit falls 57 pc to Rs 206.5 cr
Natco Pharma has reported a stark profit decline in the first quarter, largely driven by reduced sales of its leading cancer drug, lenalidomide. This led to a pronounced drop in consolidated revenues compared to the prior year. On a brighter note, the core
Announcement as on 14 August 2026

Natco Pharma shares crash 15% after weak Q4 results; net profit tanks 34% YoY
Natco Pharma shares plunged after the company reported a steep fall in fourth-quarter profit, revenue and EBITDA. Weak operating margins and lower annual earnings weighed on investor sentiment despite a one-time tax-related benefit recorded during the quar
Announcement as on 29 May 2026

Natco Pharma, Eris Lifesciences shares jump up to 6% on partnership for Semaglutide launch in India
Shares of Natco Pharma and Eris Lifesciences climbed on Tuesday after announcing a partnership to commercialise Semaglutide in India. Natco rose over 6% to its highest level since January 8, while Eris gained nearly 4%, marking its third straight session o
Announcement as on 24 February 2026

Volumes jump at Natco Pharma Ltd counter
Natco Pharma Ltd witnessed volume of 188.67 lakh shares by 14:14 IST on NSE, a 30.19 times surge over two-week average daily volume of 6.25 lakh shares
Announcement as on 16 February 2026

Announcements by Natco Pharm first page | Next page |

524816 Natco Pharm current price & indicator signals

Moving Averages for Natco Pharm

  • 5Day Average: 886.96
  • 12Day Average: 904.36
  • 20Day Average: 912.71
  • 50Day Average: 918.65
  • 100Day Average: 997.18
  • 150Day Average: 964.28
  • 200Day Average: 943.1

524816 Indicators & signals

Indicator MACD (12,26,9)

901.16, 915.18, -10.8
Indicator MACD is in negative zone

Indicator ADX (14)

6.56, 20.42, 17.91
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 47
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 524816 Natco Pharm are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
21 Fri Aug 2026 882.50 877.95 to 900.00 0.54% 0.74 times
20 Thu Aug 2026 877.75 875.30 to 894.30 -1.05% 0.68 times
19 Wed Aug 2026 887.05 883.10 to 916.60 -1.2% 0.29 times
18 Tue Aug 2026 897.80 889.70 to 900.10 0.91% 0.37 times
17 Mon Aug 2026 889.70 870.70 to 898.85 -1.41% 1.2 times
14 Fri Aug 2026 902.40 885.75 to 962.25 -5.23% 3.7 times
13 Thu Aug 2026 952.25 917.60 to 960.40 4.07% 1.64 times
12 Wed Aug 2026 915.00 906.00 to 922.00 0.89% 0.48 times
11 Tue Aug 2026 906.90 903.55 to 929.40 -0.5% 0.77 times
10 Mon Aug 2026 911.50 905.55 to 932.00 -0.62% 0.73 times
07 Fri Aug 2026 917.15 912.00 to 921.10 0.53% 0.14 times
06 Thu Aug 2026 912.35 910.00 to 932.75 -0.58% 0.75 times

Videos related to: 524816 announcements Natco Pharm announcements and dividends declared BSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

524816 announcements Natco Pharm announcements and dividends declared BSE

 

Back to top